Good morning. I appreciate you making the time.

I'll be direct: our medical cost trend with NorthRier is running 2–3 points above our regional average, and upside-only deals haven't delivered the improvement we need. My leadership expects this renewal to include real downside risk starting in year one.

I want us to stay partnered in this market, but I can't defend another soft arrangement. So where do we begin?